CDXS (Codexis) Institutional Ownership: 69.60% (As of Aug. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CDXS Codexis Inc CDXS
57 GF Score
Price $1.60
GF Value $2.57
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Codexis Institutional Ownership?

Codexis CDXS +1.60% 57 Institutional Ownership is 69.60% as of Aug. 18, 2026. GuruFocus rates CDXS with a GF Score™ of 57/100 and a GF Value™ of $2.57 (Possible Value Trap). The stock has 6 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Codexis's institutional ownership is 69.60%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Codexis's Insider Ownership is 5.96%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Codexis's Float Percentage Of Total Shares Outstanding is 98.77%.

Codexis Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Codexis's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Codexis Institutional Ownership Chart

Codexis Historical Data

The historical data trend for Codexis can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 31.95 31.90 31.24 30.75 31.01 29.97 30.48 30.48 31.79 31.20
CDXS
57GF Score
Codexis Inc CDXS
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Codexis Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 69.60% mean?
Codexis (CDXS) has a Institutional Ownership of 69.60% as of Aug. 18, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Codexis and its competitors.
Is Codexis' Institutional Ownership too high?
Codexis' current Institutional Ownership is 69.60%. Overall, Codexis has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Codexis' Institutional Ownership compare to CUE and CNTB?
Codexis' Institutional Ownership of 69.60% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Codexis and its competitors. Codexis's current Institutional Ownership is 69.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Codexis stock overvalued right now?
Based on GuruFocus' analysis, Codexis (CDXS) is currently considered Possible Value Trap. The stock's GF Value™ is $2.57, compared to a current price of $1.60 — trading 37.9% below its estimated fair value. The current Institutional Ownership is 69.60%. Codexis' overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Codexis (CDXS), the current Institutional Ownership is 69.60% as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Codexis (CDXS) Overvalued in 2026?

Based on GuruFocus' analysis, Codexis stock appears to be undervalued. The current stock price of $1.60 is trading 37.9% below its estimated GF Value™ of $2.57. GuruFocus considers Codexis to be Possible Value Trap.

Key valuation signals for CDXS:

  • Institutional Ownership: 69.60%
  • GF Value™: $2.57 vs. price of $1.60 (37.9% below fair value)
  • GF Score™: 57/100 with 6 warning signs

No single metric tells the full story. See the CDXS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Codexis Business Description

Other Exchanges 0I0X:UK4QK:Germany
Address 200 Penobscot Drive, Redwood City, CA, USA, 94063
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
57GF Score

Get the complete analysis for CDXS

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.60
Price
$2.57
GF Value